SciELO - Scientific Electronic Library Online

 
vol.28 issue1Chagas disease: reality of a frequent pathology in Santander, ColombiaLegal and ethical controversies regarding umbilical cord blood author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Medicas UIS

Print version ISSN 0121-0319

Abstract

ARENAS RUEDA, Yuli Andrea  and  PRADILLA ARENAS, Germán Lauro. Intravenous immunoglobulin as an option to treat newborn jaundice caused by ABO incompatibility. Medicas UIS [online]. 2015, vol.28, n.1, pp.91-97. ISSN 0121-0319.

Neonatal jaundice has many possible diagnoses according to the predominant type of bilirubin. The ABO incompatibility is one of the most common causes of hemolytic disease due to indirect hyperbilirubinemia. Clinical manifestations vary from asymptomatic to severe neurological symptoms, even leading with irreversible damage. Phototherapy achieves a significant decrease of bilirubin, with a low probability of side effects; however, some patients require invasive methods such as exchange transfusion. High doses of Intravenous immunoglobulin no is a treatment used nowadays. The aim of this review is to evidence there is enough literature supporting intravenous immunoglobulin as a valid alternative to treat hyperbilirubinemia by ABO incompatibility, in order to be able to reduce invasive procedures in newborns such as exchange transfusion. MÉD.UIS. 2015;28(1):91-7

Keywords : Hyperbilirubinemia; Neonatal; Jaundice; Neonatal; Immunoglobulin G; Blood Group Incompatibility; Hemolysis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )